Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type 1 Diabetes and Depression: Role of Brain Glutamate

NCT05355285 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT05355285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05355285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type 1 Diabetes and Depression: Role of Brain Glutamate
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
November 30, 2014
Enrollment
68 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depressive symptoms, major depressive disorder, type1diabetes